Trials / Recruiting
RecruitingNCT03290534
Feasibility Study to Treat Lung Cancer With the Permanently Implantable LDR CivaSheet®
- Status
- Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- CivaTech Oncology · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a feasibility study to determine the usefulness of a brachytherapy device that utilizes active components (palladium-103) of standard devices in a novel configuration, which may benefit lung cancer patients by reducing the radiation dose to critical structures, such as the heart wall, while giving a therapeutic dose to diseased tissue, such as at a surgical margin.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CivaSheet | implanting CivaSheet for localized radiation dose delivery |
Timeline
- Start date
- 2019-03-13
- Primary completion
- 2026-12-01
- Completion
- 2027-12-01
- First posted
- 2017-09-25
- Last updated
- 2025-04-04
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03290534. Inclusion in this directory is not an endorsement.